TR200101492T2 - IGF-I ve II 'yi engelleyen GH-RH'nın antagonistik analogları - Google Patents

IGF-I ve II 'yi engelleyen GH-RH'nın antagonistik analogları

Info

Publication number
TR200101492T2
TR200101492T2 TR2001/01492T TR200101492T TR200101492T2 TR 200101492 T2 TR200101492 T2 TR 200101492T2 TR 2001/01492 T TR2001/01492 T TR 2001/01492T TR 200101492 T TR200101492 T TR 200101492T TR 200101492 T2 TR200101492 T2 TR 200101492T2
Authority
TR
Turkey
Prior art keywords
analogs
inhibits igf
hgh
antagonistic analogues
antagonistic
Prior art date
Application number
TR2001/01492T
Other languages
English (en)
Inventor
V. Schally Andrew
Varga Jozsef
Zarandi Marta
Original Assignee
The Administrators Of The Tulane Educational Fund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Administrators Of The Tulane Educational Fund filed Critical The Administrators Of The Tulane Educational Fund
Publication of TR200101492T2 publication Critical patent/TR200101492T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

hGH-RH(1-29)NH2 'nin sentetik analoglarinin yeni bir dizisi ortaya konulmaktadir. Bu analoglar endojen hGH-RH'nin aktivitesini engeller ve dolayisiyla da büyüme hormonunun serbest birakilmasini önler. Geçmiste tarif edilmis olanlara kiyasla, yeni, analoglarin daha kuvvetli olan engelleyici potanslari muhtelif amino asitlerin degistirilmesi sonucu husule gelir.
TR2001/01492T 1998-11-25 1999-11-23 IGF-I ve II 'yi engelleyen GH-RH'nın antagonistik analogları TR200101492T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/199,381 US6057422A (en) 1998-11-25 1998-11-25 Antagonistic analogs of GH-RH inhibiting IGF-I and -II

Publications (1)

Publication Number Publication Date
TR200101492T2 true TR200101492T2 (tr) 2001-11-21

Family

ID=22737273

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01492T TR200101492T2 (tr) 1998-11-25 1999-11-23 IGF-I ve II 'yi engelleyen GH-RH'nın antagonistik analogları

Country Status (29)

Country Link
US (2) US6057422A (tr)
EP (1) EP1133522B1 (tr)
JP (1) JP2002530432A (tr)
KR (1) KR100629013B1 (tr)
CN (1) CN100422211C (tr)
AR (1) AR022392A1 (tr)
AT (1) ATE332310T1 (tr)
AU (1) AU757222B2 (tr)
BG (1) BG65137B1 (tr)
BR (1) BR9915512A (tr)
CA (1) CA2351665C (tr)
CO (1) CO5180565A1 (tr)
CZ (1) CZ20011794A3 (tr)
DE (1) DE69932255T2 (tr)
DK (1) DK1133522T3 (tr)
ES (1) ES2264279T3 (tr)
HK (1) HK1036461A1 (tr)
HU (1) HUP0105094A3 (tr)
IL (1) IL142899A0 (tr)
NO (1) NO20012489L (tr)
NZ (1) NZ511307A (tr)
PL (1) PL197471B1 (tr)
PT (1) PT1133522E (tr)
RU (1) RU2235099C2 (tr)
SK (1) SK7252001A3 (tr)
TR (1) TR200101492T2 (tr)
TW (1) TW585873B (tr)
UA (1) UA68407C2 (tr)
WO (1) WO2000031136A1 (tr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1412477A4 (en) * 2001-07-12 2005-12-14 Exelixis Inc GLYPICANS (GPC) USEFUL AS MODIFIERS OF IRRTK AND P21 MECHANISMS, METHODS OF USE THEREOF
US20040121407A1 (en) * 2002-09-06 2004-06-24 Elixir Pharmaceuticals, Inc. Regulation of the growth hormone/IGF-1 axis
CN1688696A (zh) * 2002-09-18 2005-10-26 蒙特利尔大学医疗中心 Ghrh类似物
TW200517400A (en) * 2003-08-05 2005-06-01 Univ Tulane Antagonistic analogs of GH-RH (2003)
US8691942B2 (en) 2008-03-28 2014-04-08 University Of Miami N- and C- terminal substituted antagonistic analogs of GH-RH
BRPI0910873A2 (pt) * 2008-03-28 2015-10-06 Us Of America Represented By The Dept Of Veterans Affairs análogos antagonistas de gh-rh substituídos nos terminais n e c
AU2009259034B2 (en) 2008-06-12 2013-10-31 Ipsen Bioinnovation Limited Suppression of cancers
US20110171191A1 (en) 2008-06-12 2011-07-14 Syntaxin Limited Suppression of neuroendocrine diseases
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
US8227421B2 (en) 2009-09-17 2012-07-24 University Of Miami Fluorinated GHRH antagonists
CN103547591A (zh) 2011-04-21 2014-01-29 瑟瑞技术公司 生长激素释放因子(grf)类似物及其用途
US9079974B2 (en) * 2011-12-21 2015-07-14 The University Of Miami GH-RH analogs with potent agonistic effects
US9393271B2 (en) 2012-12-21 2016-07-19 University Of Miami GHRH agonists for islet cell transplantation and function and the treatment of diabetes
US9855312B2 (en) 2012-12-21 2018-01-02 University Of Miami GHRH agonists for the treatment of ischemic disorders
AU2015346277B2 (en) 2014-11-12 2020-03-26 Centre Hospitalier Universitaire De Liège Treatment of hormonal disorders of growth

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659693A (en) * 1984-04-30 1987-04-21 Syntex (U.S.A.) Inc. N,N'-dialkyl substituted guanidino amino acyl residue substituted GRF-analog peptides
EP0527914A4 (en) * 1990-05-04 1993-08-11 The Administrators Of The Tulane University Educational Fund Novel synthetic grf analogs
US5550212A (en) * 1993-12-17 1996-08-27 The Administrators Of The Tulane Educational Fund Analogues of hGH-RH(1-29)NH2 having antagonistic activity
US5942489A (en) * 1996-05-03 1999-08-24 The Administrators Of The Tulane Educational Fund HGH-RH(1-29)NH2 analogues having antagonistic activity

Also Published As

Publication number Publication date
NO20012489L (no) 2001-07-04
WO2000031136A9 (en) 2001-07-19
US6057422A (en) 2000-05-02
AU757222B2 (en) 2003-02-06
TW585873B (en) 2004-05-01
HUP0105094A2 (hu) 2002-04-29
ES2264279T3 (es) 2006-12-16
AR022392A1 (es) 2002-09-04
CN1328570A (zh) 2001-12-26
PL197471B1 (pl) 2008-04-30
IL142899A0 (en) 2002-04-21
EP1133522A1 (en) 2001-09-19
SK7252001A3 (en) 2002-02-05
PT1133522E (pt) 2006-11-30
KR20010101079A (ko) 2001-11-14
NO20012489D0 (no) 2001-05-21
BG65137B1 (bg) 2007-03-30
HK1036461A1 (en) 2002-01-04
DE69932255T2 (de) 2007-05-31
PL349877A1 (en) 2002-09-23
US7026281B1 (en) 2006-04-11
HUP0105094A3 (en) 2002-05-28
CA2351665C (en) 2008-09-02
CN100422211C (zh) 2008-10-01
CO5180565A1 (es) 2002-07-30
JP2002530432A (ja) 2002-09-17
BR9915512A (pt) 2001-08-07
WO2000031136A1 (en) 2000-06-02
CZ20011794A3 (cs) 2002-02-13
RU2235099C2 (ru) 2004-08-27
DE69932255D1 (de) 2006-08-17
BG105638A (en) 2002-01-31
KR100629013B1 (ko) 2006-09-26
EP1133522B1 (en) 2006-07-05
CA2351665A1 (en) 2000-06-02
DK1133522T3 (da) 2006-11-06
AU2029100A (en) 2000-06-13
UA68407C2 (en) 2004-08-16
NZ511307A (en) 2005-01-28
ATE332310T1 (de) 2006-07-15

Similar Documents

Publication Publication Date Title
TR200101492T2 (tr) IGF-I ve II 'yi engelleyen GH-RH'nın antagonistik analogları
MX9800418A (es) Analogos de la hormona paratiroidea.
MX9703550A (es) Secretagogos de hormona del crecimiento, peptidomimeticos, de bajo peso molecular.
IL113617A0 (en) Soluble polypeptide fraction
DE69824604D1 (de) Mutierte cellulase von thermomonospora spp
TR199902997T2 (tr) "LH-RH peptit analoglari, bunlarin kullanimlari ve bunlari içeren farmasötik terkipler"
ATE81779T1 (de) Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
ATE201696T1 (de) Zyklische peptidanaloga von somatostatin
ATE279432T1 (de) Kininogen-inhibitoren
DK0896615T3 (da) Peptid fra opløselig form af acetylcholinesterase, der er aktivt som calcium-kanal-modulator
ATE146188T1 (de) Substituierungsanaloge von magaininpeptiden
EP1006126A3 (en) Osteogenic peptides
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
ATE330966T1 (de) Somatostatin-antagonisten
DE69619530T2 (de) Zyklische somatostatinanaloge mit wachstumhormon inhibierender aktivität
ATE162850T1 (de) Phospholipase c inhibitierendes peptid
DK0466498T3 (da) Fysiologisk aktive peptider med immunoregulatoriske aktiviteter
ES2058290T3 (es) Analogos de somatostatina terapeuticos.
SE8901278D0 (sv) Peptide derivatives
TH1762EX (th) เพพไทด์สังเคราะห์ที่แสดงฤทธิ์ปลดปล่อยฮอร์โมนช่วยการเติบโตของพิทูอิทารี
JPS53132539A (en) Protected amino acid or peptide having said protected amino acid residue
TR200003662T2 (tr) Yeni anjiyotensin reseptörü, aynısının üretimi ve kullanımı.
ECSP961798A (es) Peptidos de somatostatina